HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Myelodysplastic syndrome presenting as generalized granulomatous dermatitis.

AbstractBACKGROUND:
Granulomatous dermatitis has rarely been reported as a manifestation of leukemia or myelodysplastic syndrome (MDS). We describe a case of widespread granulomatous dermatitis that preceded the diagnosis of MDS by 2 years.
OBSERVATIONS:
A 71-year-old man developed a generalized, mildly pruritic eruption that slowly progressed over a 2-year period. Punch biopsy specimens demonstrated interstitial dermal granulomatous inflammation. A complete blood cell count with differential showed marked monocytosis, and the findings of a subsequent biopsy of the bone marrow confirmed MDS. Lenalidomide therapy was initiated, and the patient's skin condition improved after 6 weeks of treatment; however, his MDS progressed to acute myeloid leukemia, and he died shortly thereafter.
CONCLUSIONS:
There is a paucity of literature documenting the occurrence of granulomatous dermatitis as a manifestation of an underlying hematologic disorder. This case illustrates a striking example of widespread granulomatous dermatitis heralding the onset of MDS. It is imperative that the dermatologic community recognize the rare association of granulomatous dermatitis with myelodysplasia, because the cutaneous manifestations may be the presenting finding and can precede the development of leukemia by several years.
AuthorsSamuel J Balin, David A Wetter, Paul J Kurtin, Louis Letendre, Mark R Pittelkow
JournalArchives of dermatology (Arch Dermatol) Vol. 147 Issue 3 Pg. 331-5 (Mar 2011) ISSN: 1538-3652 [Electronic] United States
PMID21422341 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antineoplastic Agents
  • Thalidomide
  • Lenalidomide
Topics
  • Aged
  • Antineoplastic Agents (therapeutic use)
  • Biopsy
  • Blood Cell Count
  • Dermatitis (drug therapy, etiology, pathology)
  • Disease Progression
  • Granuloma (etiology, pathology)
  • Humans
  • Lenalidomide
  • Male
  • Myelodysplastic Syndromes (complications, diagnosis)
  • Pruritus (etiology)
  • Thalidomide (analogs & derivatives, therapeutic use)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: